GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FORUM MARKETS Inc (FRMM) | 8/14/2026 4:49:10 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $1,365,000 | Assets $159,031,000 | EPS -$0.73 | |
| FORUM MARKETS Inc (FRMM) | 8/13/2026 8:00:20 AM | View | Financials | Earnings | WIRE | 2Q 2026 | Rev $1,365,000 | Assets $159,031,000 | EPS -$0.73 | Export Earnings Model | |
| FORUM MARKETS Inc (FRMM) | 7/8/2026 4:13:08 PM | View | Proxy | SEC | Y 2025 | ||||||
| FORUM MARKETS Inc (FRMM) | 5/15/2026 4:35:00 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $2,859,000 | Assets $207,611,000 | EPS -$3.64 | |
| FORUM MARKETS Inc (FRMM) | 5/14/2026 8:14:05 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $2,859,000 | Assets $207,611,000 | EPS -$3.64 | Export Earnings Model | |
| FORUM MARKETS Inc (FRMM) | 4/1/2026 6:11:34 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $6,547,000 | Assets $306,297,000 | EPS -$54.32 | |
| FORUM MARKETS Inc (FRMM) | 3/31/2026 4:01:39 PM | View | Financials | Earnings | SEC | Y 2025 | Rev $2,436,831 | Assets $306,297,000 | EPS -$7.12 | Export Earnings Model | |
| ETHZilla Corp (FRMM) | 11/14/2025 5:12:43 PM | Mid | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $4,110,169 | Assets $1,009,312,988 | EPS -$16.80 | |
| ETHZilla Corp (FRMM) | 11/14/2025 8:03:41 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $4,110,169 | Assets $1,009,312,988 | EPS -$16.80 | Export Earnings Model | |
| ETHZilla Corp (FRMM) | 11/5/2025 9:21:34 AM | View | Proxy | SEC | Y 2024 | ||||||
| ETHZilla Corp (FRMM) | 9/5/2025 5:12:53 PM | View | Proxy | SEC | Y 2024 | ||||||
| 180 Life Sciences Corp. (FRMM) | 7/23/2025 4:25:12 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $10,714,161 | EPS -$0.30 | ||
| 180 Life Sciences Corp. (FRMM) | 7/7/2025 4:42:35 PM | View | Proxy | SEC | Y 2024 | ||||||
| 180 Life Sciences Corp. (FRMM) | 5/15/2025 4:34:28 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $11,650,794 | EPS -$0.67 | ||
| 180 Life Sciences Corp. (FRMM) | 5/8/2025 4:34:19 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $12,763,412 | EPS -$15.49 | ||
| 180 Life Sciences Corp. (FRMM) | 4/25/2025 4:23:07 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $12,763,412 | EPS -$15.49 | ||
| 180 Life Sciences Corp. (FRMM) | 3/31/2025 4:27:19 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $12,763,412 | EPS -$15.49 | ||
| 180 Life Sciences Corp. (FRMM) | 11/14/2024 4:51:27 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $10,469,856 | EPS -$0.85 | ||
| 180 Life Sciences Corp. (FRMM) | 11/12/2024 9:47:58 AM | View | Proxy | SEC | Y 2023 | ||||||
| 180 Life Sciences Corp. (FRMM) | 8/12/2024 5:16:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $3,911,445 | EPS $0.01 | ||
| 180 Life Sciences Corp. (FRMM) | 5/15/2024 5:19:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $3,441,740 | EPS -$1.68 | ||
| 180 Life Sciences Corp. (FRMM) | 4/29/2024 4:28:53 PM | Micro | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Assets $5,259,476 | EPS -$52.59 | ||
| 180 Life Sciences Corp. (FRMM) | 3/25/2024 6:19:07 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $5,259,476 | EPS -$52.59 | ||
| 180 Life Sciences Corp. (FRMM) | 12/26/2023 4:16:35 PM | View | Proxy | SEC | Y 2022 | ||||||
| 180 Life Sciences Corp. (FRMM) | 11/9/2023 5:17:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $4,958,085 | EPS -$1.29 | ||
| 180 Life Sciences Corp. (FRMM) | 8/15/2023 5:16:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $13,666,714 | EPS -$0.70 | ||
| 180 Life Sciences Corp. (FRMM) | 5/23/2023 4:21:24 PM | View | Proxy | SEC | Y 2022 | ||||||
| 180 Life Sciences Corp. (FRMM) | 5/15/2023 4:34:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $14,922,431 | EPS -$1.27 | ||
| 180 Life Sciences Corp. (FRMM) | 4/28/2023 5:42:38 PM | Micro | View | Financials | 10-K/A | SEC | Y 2022 ending: 12/31/2022 | Assets $19,650,248 | EPS -$18.55 | ||
| 180 Life Sciences Corp. (FRMM) | 3/31/2023 4:48:45 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $19,650,248 | EPS -$18.55 | ||
| 180 Life Sciences Corp. (FRMM) | 11/16/2022 8:31:51 AM | View | Proxy | SEC | Y 2021 | ||||||
| 180 Life Sciences Corp. (FRMM) | 11/10/2022 4:38:27 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $34,335,932 | EPS -$0.55 | ||
| 180 Life Sciences Corp. (FRMM) | 8/9/2022 10:22:35 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $53,357,513 | EPS $0.09 | ||
| 180 Life Sciences Corp. (FRMM) | 5/16/2022 7:16:52 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $59,677,315 | EPS $0.05 | ||
| 180 Life Sciences Corp. (FRMM) | 4/28/2022 5:17:03 PM | View | Proxy | SEC | Y 2021 | ||||||
| 180 Life Sciences Corp. (FRMM) | 4/28/2022 5:16:52 PM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Assets $62,713,670 | EPS -$12.96 | ||
| 180 Life Sciences Corp. (FRMM) | 3/31/2022 6:26:26 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $62,713,670 | EPS -$12.96 | ||
| 180 Life Sciences Corp. (FRMM) | 11/15/2021 6:24:06 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $65,069,767 | EPS $0.23 | ||
| 180 Life Sciences Corp. (FRMM) | 10/19/2021 6:03:12 AM | View | Proxy | SEC | Y 2020 | ||||||
| 180 Life Sciences Corp. (FRMM) | 8/16/2021 8:51:48 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $56,265,456 | EPS -$0.75 | ||
| 180 Life Sciences Corp. (FRMM) | 7/19/2021 6:15:08 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $60,112,169 | EPS -$0.58 | ||
| 180 Life Sciences Corp. (FRMM) | 7/9/2021 5:33:34 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $55,533,370 | EPS -$0.66 | ||
| 180 Life Sciences Corp. (FRMM) | 2/5/2021 5:13:02 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2020 ending: 9/30/2020 | Assets $11,024,390 | EPS -$0.05 | ||
| 180 Life Sciences Corp. (FRMM) | 2/5/2021 5:02:57 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2020 ending: 6/30/2020 | Assets $12,626,064 | EPS $0.02 | ||
| 180 Life Sciences Corp. (FRMM) | 11/24/2020 6:15:11 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $11,024,390 | EPS -$0.05 | ||
| KBL MERGER CORP. IV (FRMM) | 8/20/2020 6:13:43 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $12,626,064 | EPS $0.02 | ||
| KBL MERGER CORP. IV (FRMM) | 6/30/2020 6:19:40 AM | View | Proxy | SEC | Y 2019 | ||||||
| KBL MERGER CORP. IV (FRMM) | 5/22/2020 4:13:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $12,367,884 | EPS -$0.05 | ||
| KBL MERGER CORP. IV (FRMM) | 4/7/2020 5:11:47 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $51,884,468 | EPS -$0.02 | ||
| KBL MERGER CORP. IV (FRMM) | 3/24/2020 5:26:45 PM | View | Proxy | SEC | Y 2019 | ||||||
| KBL MERGER CORP. IV (FRMM) | 11/19/2019 6:03:28 AM | View | Proxy | SEC | Y 2018 | ||||||
| KBL MERGER CORP. IV (FRMM) | 11/12/2019 5:20:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $51,572,662 | EPS -$0.01 | ||
| KBL MERGER CORP. IV (FRMM) | 8/9/2019 5:04:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $50,237,154 | |||
| KBL MERGER CORP. IV (FRMM) | 5/20/2019 9:57:43 AM | View | Proxy | SEC | Y 2018 | ||||||
| KBL MERGER CORP. IV (FRMM) | 5/13/2019 2:26:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $66,471,435 | EPS $0.02 | ||
| KBL MERGER CORP. IV (FRMM) | 4/1/2019 5:27:44 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $118,436,832 | EPS $0.07 | ||
| KBL MERGER CORP. IV (FRMM) | 2/20/2019 5:25:56 PM | View | Proxy | SEC | Y 2018 | ||||||
| KBL MERGER CORP. IV (FRMM) | 11/28/2018 5:19:45 PM | View | Proxy | SEC | Y 2017 | ||||||
| KBL MERGER CORP. IV (FRMM) | 11/9/2018 4:35:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $118,220,961 | EPS $0.02 | ||
| KBL MERGER CORP. IV (FRMM) | 8/14/2018 6:15:33 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $117,954,772 | EPS $0.01 | ||
| KBL MERGER CORP. IV (FRMM) | 5/15/2018 5:15:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $117,307,526 | EPS $0.01 | ||
| KBL MERGER CORP. IV (FRMM) | 3/29/2018 2:28:11 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | ||||
| KBL MERGER CORP. IV (FRMM) | 11/13/2017 4:46:53 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | ||||
| KBL MERGER CORP. IV (FRMM) | 8/14/2017 6:16:21 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 |